The Qsep Ultra by BiOptic, the world's first two-in-one nucleic acid amplification (PCR) and analysis instrument, will accelerate the popularization of nucleic acid testing products at a more affordable price.

The Qsep Ultra, with its innovative innovation, precision and speed, and versatile applications, will disrupt the complex process of traditional molecular testing and make it more affordable, which will help accelerate the adoption of nucleic acid testing and make real-time on-site testing and sentinel care more popular.

The Chairman Tsai pointed out that traditional genetic testing requires four complex processes, including sampling, extraction, polymerisation (PCR) chain reaction (PCR nucleic acid amplification) and biological fragment analysis, which can be time-consuming and costly. Following the successful development of nucleic acid extraction-free technology, the new Qsep Ultra system is a dual-function system that requires only two steps, i.e. sample collection, direct PCR reagent kit and a simple, fully automated process to complete the nucleic acid test and produce a digital analysis report.

The product is expected to accelerate the spread of nucleic acid testing in various fields such as medical and health, food safety, agriculture and livestock, and even aquaculture, as well as to achieve real-time monitoring and prevention of highly infectious diseases with huge cost savings.

BiOptic's new Qsep capillary electrophoresis system is an open architecture and an innovative new ecosystem, like an Android platform for the biomedical industry.